My Portfolio
+
LINK YOUR PORTFOLIO

Ionis Pharmaceuticals Inc IONS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 06/03/26 EDT
73.82UNCH (UNCH)
Volume
48,376
Close
73.82quote price arrow up+0.85 (+1.16%)
Volume
1,255,366
52 week range
33.95 - 86.74
Loading...
  • Open72.68
  • Day High74.12
  • Day Low72.02
  • Prev Close72.97
  • 52 Week High86.74
  • 52 Week High Date02/05/26
  • 52 Week Low33.95
  • 52 Week Low Date06/03/25

Key Stats

  • Market Cap12.20B
  • Shares Out165.26M
  • 10 Day Average Volume1.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.37

KEY STATS

  • Open72.68
  • Day High74.12
  • Day Low72.02
  • Prev Close72.97
  • 52 Week High86.74
  • 52 Week High Date02/05/26
  • 52 Week Low33.95
  • 52 Week Low Date06/03/25
  • Market Cap12.20B
  • Shares Out165.26M
  • 10 Day Average Volume1.69M
  • Dividend-
  • Dividend Yield-
  • Beta0.37

RATIOS/PROFITABILITY

  • EPS (TTM)-2.10
  • P/E (TTM)-35.13
  • Fwd P/E (NTM)-19.30
  • EBITDA (TTM)-338.65M
  • ROE (TTM)-67.62%
  • Revenue (TTM)1.058B
  • Gross Margin (TTM)98.35%
  • Net Margin (TTM)-30.90%
  • Debt To Equity (MRQ)476.08%

EVENTS

  • Earnings Date07/28/2026(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Profile

MORE
Ionis Pharmaceuticals, Inc. develops six marketed medicines for serious diseases, including medicines for neurologic and cardiovascular diseases. Its marketed medicines consist of TRYNGOLZA, WAINUA (eplontersen), SPINRAZA (nusinersen), QALSODY (tofersen), TEGSEDI (inotersen) and WAYLIVRA (volanesorsen). TRYNGOLZA reduces triglyceride levels in adults with familial chylomicronemia syndrome (FCS). WAINUA is approved for the treatment of the polyneuropathy of hereditary...
Joseph Loscalzo M.D., Ph.D.
Independent Chairman of the Board
Brett Monia Ph.D.
Chief Executive Officer, Director
Elizabeth Hougen
Chief Financial Officer, Executive Vice President - Finance
Eugene Schneider M.D.
Executive Vice President, Chief Clinical Development and Operations Officer
Patrick O'Neil Esq.
Executive Vice President, Chief Legal Officer, General Counsel and Corporate Secretary
Address
2855 Gazelle Court
Carlsbad, CA
92010
United States